Radiation Oncology Committee
Radiation Oncology Committee Leadership
Chair
Evan Wuthrick, MD
Vice Chair
Charles B. Simone II, MD
Vice Chair
Diandra Ayala-Peacock, MD
Working Groups
Particle Therapy Working Group (Formerly Proton Working Group)
Chair
Charles B. Simone II, MD
Core Committee Members
Core Committee Members
- Diandra Ayala-Peacock
- Mark Bernard (GYN Liaison)
- Walter Bosch (Ex-Officio)
- Jimmy Caudell (H&N Liaison)
- Jason Chan (H&N Liaison)
- Steven Chmura (Breast Liaison)
- Stephen Chun (Lung Liaison)
- Eric Donnelly (GYN Liaison)
- Hiram Gay (GU Liaison)
- Willam Hall (GI Liaison)
- Matthew Harkenrider
- Daniel Krauss (GU Liaison)
- Stephen Kry (IROC Houston)
- Kimberly Mak (GI Liaison)
- Pamela Samson (Lung Liaison)
- Charles Simone (Vice Chair)
- Christina Tsien (Brain Liaison)
- Tony Wang (Brain Liaison)
- Dian Wang (Sarcoma Liaison)
- Philip Wong (Sarcoma Liaison)
- Evan Wuthrick (Chair)
- Ying Xiao (Med Physics Liaison)
General Committee Members
- Matthew Abrams
- Jes Alexander
- Naba Ali
- Fiori Alite
- Prasanna G. Alluri
- Therese Youssef Andraos
- Anthony J. Apicelli, III
- Musaddiq Awan
- Shahed N. Badiyan
- Christopher A. Barker
- Parul N. Barry
- James E. Bates
- Rohini K. Bhatia
- Matthew J. Boyer
- Christopher L. Brett
- Anna M. Brown
- Cameron M. Callaghan
- Shauna Campbell
- Dana Casey
- Julie Choi
- Alexandra N. De Leo
- Cristina DeCesaris
- Vishal R. Dhere
- Kevin Du
- Marie Duclos
- Jacob Eckstein
- Jason Efstathiou (Ex-Officio)
- Denise Fabian
- Michael R. Folkert
- Idalid Franco
- Matthew Gallitto
- Ramesh Gopal
- Garrett Green
- Craig E. Grossman
- Alexander N. Hanania
- Jared H. Hara
- Comron Hassanzadeh
- David P. Horowitz
- Andrew J. Huang
- James R Janopaul-Naylor
- Anuja Jhingran
- Gavin P. Jones
- Jung Julie Kang
- Nirav S. Kapadia
- William R. Kennedy
- Aparna H. Kesarwala
- Hyun Kim
- Connor J. Kinslow
- Lawrence Koutcher
- Ryan D. Kraus
- Editha Krueger
- Anna Lee
- Eric Lehrer
- Diane C. Ling
- Raymond M. Luke
- Mitchell Machtay (Ex-Officio)
- Adrianna H. Masters
- Shalini Moningi
- Ceferino Obcemea
- Russell Palm
- Sagar A. Patel
- Haley Perlow
- Ryan M. Phillips
- Anne W. Rajkumar
- Srinivas Raman
- Niema B. Razavian
- Krishna Reddy
- Kristin Redmond
- Benjamin J. Rich
- Anupam Rishi
- David M Routman
- Naoyuki G. Saito
- Anurag Saraf
- Nikhil T. Sebastian
- Steven Seyedin
- Chirag Shah
- Rohil Shekher
- Xinglei Shen
- George Shenouda
- Wenyin Shi
- Jay C. Shiao
- Rebecca M. Shulman
- Zain Siddiqui
- Austin J. Sim
- Nicole Simone
- Raj Singh
- Lindsey Sloan
- Catherine S. Spina
- Crystal S. Taswell
- Nitika Thawani
- Horatio Thomas
- Diego Augusto Santos Toesca
- Aruna Turaka
- Prashant Vempati
- Bhanu Prasad Venkatesulu
- Adam Wolfe
- Daniel X. Yang
- George Q. Yang
- Jonathan T. Yang
- Emi J. Yoshida
- Melissa R. Young
- Youssef Zeidan
- Yuanyuan Zhang
- Andrew H. Zureick
Resources
Radiation Oncology Committee Member Job Description
6th Annual NRG RO Symposium: The State Of Adaptive Radiation Therapy
5th Annual NRG RO Symposium: Current Status of the Biology, Physics, and Clinical Trials Using FLASH
4th Annual NRG RO Symposium: Radio Protectors Next Generation
Presentations 3rd Annual RO Symposium “Radiopharmaceutical Therapy (RPT)”
Amir Irvani, MD: “Overview of Opportunities of RPT in the NCTN (Radiation dosimetry in RPT trials)”
Charles Kunos, MD, PhD: “NIH Commitment – ETCTN” (audio only)
Hiram Gay, MD: “PI Update on NCI Protocol #10301”
Jyoti Malhortra, MD, MPH: “PI Update on Protocol #10302”
RO Symposium Radiopharmaceutical Therapy (RPT) Recording (Kunos presentation removed)
RO Committee Updates Recording
Presentations 2nd Annual RO Symposium on Artificial Intelligence and Machine Learning in Radiation Oncology
AI Applications in NRG Oncology and IROC
Bringing AI to the Oncology Clinic
The Future of AI in Radiation Therapy Research and Planning
CONTACT
EMAIL: Info@nrgradonccomm
CONTACT
EMAIL: Info@nrgradonccomm
CONTACT US: ManfrediD@NRGOncology.org
Support NRG Oncology.
Help Our Cause.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More